2015 VAM: 2303 - Lessons on Asthma from the Inner City: Pathogenesis, Phenotype, Treatment, and Prevention
This recording discusses how asthma continues to be a major illness for patients of all ages and locations. In US inner cities, asthma has an even greater impact as its prevalence, morbidity and mortality are higher than elsewhere. A major unmet gap in asthma is the need to understand the potentially unique needs and mechanisms of asthma in the inner city, to advance effective treatment for this high risk group, and to develop treatment approaches to not only improve control but to develop concepts for disease prevention.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by June 30, 2017. Any credit request on or after July 1, 2017 will be subject to an administrative fee.
System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Discuss the phenotype characteristics of difficult-to-treat asthma
2. Discuss environmental allergen-microbiome factors in the development of asthma and inflammatory responses
3. Discuss IgE-directed treatment approaches to improve disease control
Dr. William W. Busse, MD FAAAAI, University of Wisconsin School of Medicine and Public Health, Madison, WI
Dr. Susan V. Lynch, PhD, University of California San Francisco, San Francisco, CA
Dr. Stephen J. Teach, MD, Children's National Health System, Washington, DC
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.